This selectivity could be especially relevant in chronic inflammatory diseases such as rheumatoid arthritis and systemic lupus erythematosus glomerulonephritis, where dysregulated ADAM17–iRhom2 activity plays a critical role (5, 6). Here, ADAM17 is linked to rheumatoid arthritis.